Colorectal Cancer | Tumor

CURE’s colorectal cancer page is an extensive resource of cancer information featuring the latest colorectal cancer news, expert oncologist insights on the latest cancer treatments, oncology research, advocacy efforts, and medical data on colorectal cancer.

The Significance of the Subcutaneous Opdivo FDA Approval in Solid Tumors

January 20th 2025, 2:00pm

Article

Dr. Balazs Halmos discusses the significance of the approval of subcutaneous Opdivo and what this treatment formulation means for those with solid tumors.

Carrying the Torch: From Colorectal Cancer Survivor to Advocate

January 17th 2025, 6:00pm

Article

As someone who has overcome colorectal cancer, I reflect on the support I received from others and vow to continue their legacy of advocacy.

FDA Approves Lumakras with Vectibix in KRAS G12C+ Colorectal Cancer

January 16th 2025, 11:50pm

Article

The FDA has approved Lumakras with Vectibix for adults with KRAS G12C-mutated metastatic colorectal cancer who received chemotherapy.

How I Navigated a Colon Cancer Diagnosis at Age 34

December 30th 2024, 6:00pm

Article

Receiving a diagnosis of colon cancer at age 34 was such a shocking experience, but it has helped me become more strong-willed.

Unparalleled Devotion to Her Patients With Cancer

December 28th 2024, 3:00pm

Article

Even after a personal connection to cancer, oncology nurse Megan has embraced the cancer space as her passion.

Subcutaneous Opdivo Receives FDA Approval for Advanced, Metastatic Solid Tumors

December 27th 2024, 6:22pm

Article

Opdivo Qvantig received FDA approval for all previously approved indications in solid tumors.

FDA Grants Jemperli Breakthrough Therapy Designation in dMMR/MSI-H Rectal Cancer

December 21st 2024, 7:00pm

Article

Jemperli received breakthrough therapy designation by the FDA for locally advanced mismatch repair deficient/microsatellite instability-high rectal cancer.

FDA Approves Braftovi Plus Erbitux and Chemo for Metastatic Colorectal Cancer Subset

December 20th 2024, 7:03pm

Article

Braftovi received accelerated approval with Erbitux and mFOLFOX6 for metastatic colorectal cancer with a BRAF V600E mutation.

MRIs May Predict Organ Preservation, Survival in Rectal Cancer

December 6th 2024, 2:00pm

Article

MRIs were able to predict organ preservation and survival with the “watch-and-wait” approach in patients with rectal cancer.

Loss and Life Have Given Me a Wealth of Gratitude After Cancer

December 3rd 2024, 6:00pm

Article

When my grandmother passed away one Thanksgiving after my colon cancer diagnosis, I realized how grateful I am for her life and my own as a survivor.